Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| macrophage | 37 studies | 45% ± 16% | |
| conventional dendritic cell | 28 studies | 48% ± 15% | |
| classical monocyte | 26 studies | 48% ± 16% | |
| non-classical monocyte | 23 studies | 54% ± 15% | |
| monocyte | 22 studies | 43% ± 14% | |
| dendritic cell | 15 studies | 44% ± 18% | |
| myeloid cell | 13 studies | 44% ± 19% | |
| neutrophil | 7 studies | 33% ± 9% | |
| alveolar macrophage | 6 studies | 46% ± 14% | |
| plasmacytoid dendritic cell | 6 studies | 24% ± 6% | |
| mononuclear phagocyte | 5 studies | 47% ± 18% | |
| microglial cell | 5 studies | 37% ± 16% | |
| monocyte-derived dendritic cell | 4 studies | 42% ± 28% | |
| leukocyte | 4 studies | 27% ± 1% | |
| intermediate monocyte | 4 studies | 51% ± 10% | |
| inflammatory macrophage | 3 studies | 32% ± 17% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| peripheral blood | 8 studies | 21% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| lung | 100% | 1043.61 | 576 / 578 | 94% | 18.41 | 1091 / 1155 |
| breast | 83% | 166.81 | 379 / 459 | 96% | 13.92 | 1073 / 1118 |
| prostate | 87% | 138.10 | 213 / 245 | 73% | 5.13 | 366 / 502 |
| intestine | 79% | 191.98 | 766 / 966 | 79% | 8.66 | 415 / 527 |
| brain | 64% | 143.11 | 1690 / 2642 | 94% | 14.26 | 660 / 705 |
| thymus | 71% | 97.57 | 466 / 653 | 84% | 9.59 | 506 / 605 |
| kidney | 61% | 101.52 | 54 / 89 | 92% | 16.04 | 826 / 901 |
| adrenal gland | 94% | 218.42 | 243 / 258 | 48% | 3.11 | 111 / 230 |
| bladder | 71% | 130.76 | 15 / 21 | 69% | 8.31 | 350 / 504 |
| liver | 64% | 118.92 | 144 / 226 | 75% | 7.11 | 305 / 406 |
| esophagus | 51% | 64.36 | 732 / 1445 | 87% | 7.33 | 160 / 183 |
| uterus | 56% | 59.45 | 95 / 170 | 78% | 7.68 | 359 / 459 |
| stomach | 48% | 73.74 | 171 / 359 | 85% | 11.96 | 244 / 286 |
| skin | 49% | 49.41 | 881 / 1809 | 81% | 12.83 | 382 / 472 |
| ovary | 45% | 49.42 | 81 / 180 | 73% | 5.53 | 312 / 430 |
| pancreas | 28% | 38.23 | 91 / 328 | 89% | 12.04 | 158 / 178 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 70.20 | 29 / 29 |
| spleen | 100% | 3798.34 | 241 / 241 | 0% | 0 | 0 / 0 |
| adipose | 92% | 313.49 | 1111 / 1204 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 89% | 15.64 | 40 / 45 |
| peripheral blood | 85% | 8680.18 | 789 / 929 | 0% | 0 | 0 / 0 |
| blood vessel | 62% | 154.38 | 822 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 39% | 3.67 | 31 / 80 |
| heart | 34% | 39.04 | 296 / 861 | 0% | 0 | 0 / 0 |
| muscle | 4% | 3.35 | 29 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007166 | Biological process | cell surface receptor signaling pathway |
| GO_0006955 | Biological process | immune response |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0004888 | Molecular function | transmembrane signaling receptor activity |
| Gene name | IGSF6 |
| Protein name | Immunoglobulin superfamily member 6 Immunoglobulin superfamily member 6 (IgSF6) (Protein DORA) |
| Synonyms | DORA |
| Description | |
| Accessions | ENST00000638543.2 ENST00000268389.6 ENST00000569602.1 O95976 ENST00000639480.2 H3BNM0 |